Sort
53,477 grants matching “addiction”
PTPRD phosphatase inhibitors for stimulant use disorders
$1,453,896George R Uhl · University Of Maryland Baltimore · UG3 · FY2022 · DA
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)
$1,452,137Michael D Stein · Boston University Medical Campus · P01 · FY2022 · AA
C57BI/6 Mouse Lines Expressing CRE-Recombinase in the Nervous System
$1,451,955Ulrich Mueller · Scripps Research Institute, The · U01 · FY2007 · MH
DRUGS OF ABUSE - ROLE OF PROTEIN PHOSPHORYLATION
$1,451,548Paul Greengard · Rockefeller University · P01 · FY2015 · DA
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD
$1,451,070Sandeep Patil · Praxis Bioresearch, Llc · R44 · FY2021 · AG
Oncogenic mechanisms and molecular targets in lymphoma
$1,450,380Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Clinical development of mechanism-based lymphoma therapies
$1,450,380Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,450,380Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Functional genomic screens for molecular targets in cancer
$1,450,380Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Alcohol Center for Translational Genetics (ACTG)
$1,450,160Patricia H Janak · University Of California, San Francisco · P50 · FY2013 · AA
Coordinated medical treatment of opioid use disorder and infectious disease
$1,450,097Sandra Ann Springer · Yale University · U01 · FY2019 · TR
DRUGS OF ABUSE--ROLE OF PROTEIN PHOSPHORYLATION
$1,448,938Rockefeller University · P01 · FY2003 · DA
Center for Adaptive Treatment of Cigarette Addiction
$1,448,439Jed E Rose · Duke University · P50 · FY2014 · DA
Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse
$1,448,427Chang-Guo Zhan · University Of Kentucky · UH3 · FY2018 · DA
Methadone Dosing System (MDS)
$1,447,789Patrik Schmidle · Cari Health, Inc. · U44 · FY2025 · DA
Development of a flagellin-cocaine conjugate vaccine
$1,447,504Steven B. Mizel · Wake Forest University Health Sciences · RC2 · FY2010 · DA
The Ohio Valley Node of the Clinical Trials Network
$1,446,804T John Winhusen · University Of Cincinnati · UG1 · FY2021 · DA
Profiling the human gut microbiome for potential analgesic bacterial therapies
$1,446,416Philip Peter Strandwitz · Holobiome, Inc. · R34 · FY2021 · NS
Oncogenic mechanisms and molecular targets in lymphoma
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Clinical development of mechanism-based lymphoma therapies
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Functional genomic screens for molecular targets in cancer
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Kentucky Women's Justice Community Overdose Innovation Network - Phase II
$1,445,488Michele Staton · University Of Kentucky · RM1 · FY2025 · DA
Center on Intersystem Regulation by Drugs of Abuse
$1,445,477Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2020 · DA
Research Resource for Integrated Glycotechnology
$1,445,343James H Prestegard · University Of Georgia · P41 · FY2009 · RR